Evaluation of clinicopathologic and Survival Characteristic of Childhood and Adolescent Hodgkin's lymphoma

F. Binesh, A. Hashemi, Nazila Naghibzadeh, F. Pourhosseini, S. Mirhosseini
{"title":"Evaluation of clinicopathologic and Survival Characteristic of Childhood and Adolescent Hodgkin's lymphoma","authors":"F. Binesh, A. Hashemi, Nazila Naghibzadeh, F. Pourhosseini, S. Mirhosseini","doi":"10.18502/ijpho.v10i4.4403","DOIUrl":null,"url":null,"abstract":"Background: Given that Hodgkin’s lymphoma (HL) accounts for 5%–6% of pediatric malignancies, we investigated the clinical characteristics and survival of pediatric patients with HL in our center. \nMaterials and methods: In this cross sectional and retrospective study, the medical charts of all patients under the age of 18 diagnosed with HL from 2006 to 2016 at Shahid Sadoughi Hospital Yazd, Iran, were retrieved. Data were analyzed by SPSS (version 18) using K square and T-Test. Survival was analyzed using Kaplan-Meier estimates, and multivariate analysis was performed using the Cox regression method. \nResults: This study included 34 patients. In terms of gender, there were 20 boys and 14 girls in this study. The mean age of the patients was 10.42 years. The most common subtype of HL was mixed cellularity. Regarding disease stage, 55.9% of the patients were in stage I. All subtypes except for nodular sclerosis were more common in boys. The mean survival of patients in this study was 151.68 months. At the end of the study, there was just one death. The 5-year survival of patients was 100% and the 10-year survival was 94%. There was no significant relationship between survival and sex, histologic subtype, or the stage of the disease. \nConclusion: The results of the current study showed that majority of our patients had been diagnosed in a low stage and we achieved the best results for 5- and 10- year- overall survival through applied treatment.","PeriodicalId":44212,"journal":{"name":"Iranian Journal of Pediatric Hematology and Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2020-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pediatric Hematology and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijpho.v10i4.4403","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Given that Hodgkin’s lymphoma (HL) accounts for 5%–6% of pediatric malignancies, we investigated the clinical characteristics and survival of pediatric patients with HL in our center. Materials and methods: In this cross sectional and retrospective study, the medical charts of all patients under the age of 18 diagnosed with HL from 2006 to 2016 at Shahid Sadoughi Hospital Yazd, Iran, were retrieved. Data were analyzed by SPSS (version 18) using K square and T-Test. Survival was analyzed using Kaplan-Meier estimates, and multivariate analysis was performed using the Cox regression method. Results: This study included 34 patients. In terms of gender, there were 20 boys and 14 girls in this study. The mean age of the patients was 10.42 years. The most common subtype of HL was mixed cellularity. Regarding disease stage, 55.9% of the patients were in stage I. All subtypes except for nodular sclerosis were more common in boys. The mean survival of patients in this study was 151.68 months. At the end of the study, there was just one death. The 5-year survival of patients was 100% and the 10-year survival was 94%. There was no significant relationship between survival and sex, histologic subtype, or the stage of the disease. Conclusion: The results of the current study showed that majority of our patients had been diagnosed in a low stage and we achieved the best results for 5- and 10- year- overall survival through applied treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿童和青少年霍奇金淋巴瘤的临床病理和生存特征评价
背景:鉴于霍奇金淋巴瘤(Hodgkin’s lymphoma, HL)占儿科恶性肿瘤的5%-6%,我们调查了本中心儿童HL患者的临床特征和生存率。材料与方法:本横断面回顾性研究检索了伊朗亚兹德Shahid Sadoughi医院2006 - 2016年所有18岁以下HL患者的病历。数据采用SPSS (version 18)进行K方检验和t检验。生存率分析采用Kaplan-Meier估计,多变量分析采用Cox回归法。结果:本研究纳入34例患者。在性别方面,本研究中有20名男孩和14名女孩。患者平均年龄10.42岁。最常见的HL亚型为混合细胞型。在疾病分期方面,55.9%的患者为i期。除结节性硬化症外,所有亚型均以男孩多见。本研究患者的平均生存期为151.68个月。在研究结束时,只有一人死亡。5年生存率为100%,10年生存率为94%。生存率与性别、组织学亚型或疾病分期无显著关系。结论:目前的研究结果表明,我们的大多数患者诊断为低期,通过应用治疗,我们获得了5年和10年总生存期的最佳结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
33.30%
发文量
33
期刊最新文献
Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center Immune Thrombocytopenic Purpura: An uncommon manifestation of Hepatitis A with acute liver failure Frequency of Red Cell Alloimmunization in Patients with Thalassemia Major: A Report from the Southwest of Iran Parvovirus B19 Infection May Potentially Determine the Fate of Hematopoiesis by Altering the Human Bone Marrow Mesenchymal Stem Cells Differentiation Estimation of Secondary Cancer Risk of Radiosensitive Organs for Leukemia from Head Radiotherapy in Pediatric Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1